Search
Now showing items 1-1 of 1
Polymorphic repeat in AIB1 does not alter breast cancer risk
(BioMed Central, 2000)
We assessed the association between a glutamine repeat polymorphism in AIB1 and breast cancer risk in a case-control study (464 cases, 624 controls) nested within the Nurses' Health Study cohort. We observed no association ...